Department of Diagnostic Radiology, Tan Tock Seng Hospital, Jalan Tan Tock Seng, Singapore 308433, Singapore.
Clin Radiol. 2014 Jan;69(1):1-10. doi: 10.1016/j.crad.2013.07.022. Epub 2013 Sep 10.
The internationally accepted diagnostic criteria for hepatocellular carcinoma (HCC) in cirrhosis are highly accurate for large tumours, but offer relatively low sensitivity for small (<2 cm) tumours. Diffusion-weighted imaging (DWI) is a functional magnetic resonance imaging (MRI) technique that has been studied extensively as an aid to visualize various abdominal malignancies, including HCC in cirrhosis. DWI maps water diffusivity, which in HCC may be restricted as a result of changes ensuing from hepatocarcinogenesis. The present review is based on up-to-date evidence and describes the strengths and weaknesses of DWI, both as a standalone technique and as an adjunct sequence to conventional protocols, in the diagnosis, staging, prognostication, and assessment of treatment response of HCC in cirrhosis.
国际上公认的肝硬化肝细胞癌(HCC)诊断标准对大肿瘤具有高度准确性,但对小肿瘤(<2cm)的敏感性相对较低。扩散加权成像(DWI)是一种功能磁共振成像(MRI)技术,已被广泛研究作为辅助手段来可视化各种腹部恶性肿瘤,包括肝硬化中的 HCC。DWI 图显示水扩散度,在 HCC 中,由于肝癌发生的变化,可能会受到限制。本综述基于最新的证据,描述了 DWI 的优缺点,无论是作为独立技术还是作为常规方案的辅助序列,在肝硬化 HCC 的诊断、分期、预后和治疗反应评估中的作用。